MCL coexpression mm9:631: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 3: | Line 3: | ||
|coexpression_dpi_cluster_scores_median=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.142413261346553,0.433721247851683,0.935790827313531,0.605549593830704,0.540108555340281,0.206537122113033,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |coexpression_dpi_cluster_scores_median=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.142413261346553,0.433721247851683,0.935790827313531,0.605549593830704,0.540108555340281,0.206537122113033,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | ||
|gostat_on_MCL_coexpression=GO:0032962;positive regulation of inositol trisphosphate biosynthetic process;0.00375270495224433;18736!GO:0032959;inositol trisphosphate biosynthetic process;0.00375270495224433;18736!GO:0032958;inositol phosphate biosynthetic process;0.00375270495224433;18736!GO:0032960;regulation of inositol trisphosphate biosynthetic process;0.00375270495224433;18736!GO:0006021;inositol biosynthetic process;0.00375270495224433;18736!GO:0043647;inositol phosphate metabolic process;0.00375270495224433;18736!GO:0032957;inositol trisphosphate metabolic process;0.00375270495224433;18736!GO:0060133;somatotropin secreting cell development;0.00375270495224433;18736!GO:0060126;somatotropin secreting cell differentiation;0.00450312257623173;18736!GO:0043567;regulation of insulin-like growth factor receptor signaling pathway;0.00450312257623173;18736!GO:0045913;positive regulation of carbohydrate metabolic process;0.0050033324553003;18736!GO:0043255;regulation of carbohydrate biosynthetic process;0.0050033324553003;18736!GO:0006109;regulation of carbohydrate metabolic process;0.00643250353835337;18736!GO:0021984;adenohypophysis development;0.00643250353835337;18736!GO:0008340;determination of adult life span;0.00700408972726694;18736!GO:0048009;insulin-like growth factor receptor signaling pathway;0.00794538066611113;18736!GO:0006020;inositol metabolic process;0.00794538066611113;18736!GO:0010259;multicellular organismal aging;0.00833751668703983;18736!GO:0021983;pituitary gland development;0.0142145434083468;18736!GO:0021536;diencephalon development;0.0150009504920605;18736!GO:0040018;positive regulation of multicellular organism growth;0.0150009504920605;18736!GO:0001708;cell fate specification;0.0150009504920605;18736!GO:0019319;hexose biosynthetic process;0.0150009504920605;18736!GO:0046165;alcohol biosynthetic process;0.0150009504920605;18736!GO:0046364;monosaccharide biosynthetic process;0.0150009504920605;18736!GO:0045927;positive regulation of growth;0.0150009504920605;18736!GO:0007568;aging;0.0155556883470946;18736!GO:0030183;B cell differentiation;0.0187465618727708;18736!GO:0035270;endocrine system development;0.0248141852991228;18736!GO:0040014;regulation of multicellular organism growth;0.0259831151355832;18736!GO:0035264;multicellular organism growth;0.0294896781300526;18736!GO:0048732;gland development;0.0346440524221495;18736!GO:0016051;carbohydrate biosynthetic process;0.0358591910391614;18736!GO:0042113;B cell activation;0.0374417210532664;18736!GO:0030098;lymphocyte differentiation;0.0393597288025601;18736!GO:0003682;chromatin binding;0.0393961055216672;18736!GO:0030900;forebrain development;0.0393961055216672;18736!GO:0045165;cell fate commitment;0.0393961055216672;18736!GO:0002521;leukocyte differentiation;0.0486140962192843;18736!GO:0019318;hexose metabolic process;0.0486140962192843;18736!GO:0005996;monosaccharide metabolic process;0.0488823455569572;18736!GO:0031326;regulation of cellular biosynthetic process;0.0494922157546636;18736! | |gostat_on_MCL_coexpression=GO:0032962;positive regulation of inositol trisphosphate biosynthetic process;0.00375270495224433;18736!GO:0032959;inositol trisphosphate biosynthetic process;0.00375270495224433;18736!GO:0032958;inositol phosphate biosynthetic process;0.00375270495224433;18736!GO:0032960;regulation of inositol trisphosphate biosynthetic process;0.00375270495224433;18736!GO:0006021;inositol biosynthetic process;0.00375270495224433;18736!GO:0043647;inositol phosphate metabolic process;0.00375270495224433;18736!GO:0032957;inositol trisphosphate metabolic process;0.00375270495224433;18736!GO:0060133;somatotropin secreting cell development;0.00375270495224433;18736!GO:0060126;somatotropin secreting cell differentiation;0.00450312257623173;18736!GO:0043567;regulation of insulin-like growth factor receptor signaling pathway;0.00450312257623173;18736!GO:0045913;positive regulation of carbohydrate metabolic process;0.0050033324553003;18736!GO:0043255;regulation of carbohydrate biosynthetic process;0.0050033324553003;18736!GO:0006109;regulation of carbohydrate metabolic process;0.00643250353835337;18736!GO:0021984;adenohypophysis development;0.00643250353835337;18736!GO:0008340;determination of adult life span;0.00700408972726694;18736!GO:0048009;insulin-like growth factor receptor signaling pathway;0.00794538066611113;18736!GO:0006020;inositol metabolic process;0.00794538066611113;18736!GO:0010259;multicellular organismal aging;0.00833751668703983;18736!GO:0021983;pituitary gland development;0.0142145434083468;18736!GO:0021536;diencephalon development;0.0150009504920605;18736!GO:0040018;positive regulation of multicellular organism growth;0.0150009504920605;18736!GO:0001708;cell fate specification;0.0150009504920605;18736!GO:0019319;hexose biosynthetic process;0.0150009504920605;18736!GO:0046165;alcohol biosynthetic process;0.0150009504920605;18736!GO:0046364;monosaccharide biosynthetic process;0.0150009504920605;18736!GO:0045927;positive regulation of growth;0.0150009504920605;18736!GO:0007568;aging;0.0155556883470946;18736!GO:0030183;B cell differentiation;0.0187465618727708;18736!GO:0035270;endocrine system development;0.0248141852991228;18736!GO:0040014;regulation of multicellular organism growth;0.0259831151355832;18736!GO:0035264;multicellular organism growth;0.0294896781300526;18736!GO:0048732;gland development;0.0346440524221495;18736!GO:0016051;carbohydrate biosynthetic process;0.0358591910391614;18736!GO:0042113;B cell activation;0.0374417210532664;18736!GO:0030098;lymphocyte differentiation;0.0393597288025601;18736!GO:0003682;chromatin binding;0.0393961055216672;18736!GO:0030900;forebrain development;0.0393961055216672;18736!GO:0045165;cell fate commitment;0.0393961055216672;18736!GO:0002521;leukocyte differentiation;0.0486140962192843;18736!GO:0019318;hexose metabolic process;0.0486140962192843;18736!GO:0005996;monosaccharide metabolic process;0.0488823455569572;18736!GO:0031326;regulation of cellular biosynthetic process;0.0494922157546636;18736! | ||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_uberon=UBERON:0000007!3.71e-65!8;UBERON:0003296!3.71e-65!8;UBERON:0010133!3.71e-65!8;UBERON:0001894!2.77e-52!10;UBERON:0006222!2.77e-52!10;UBERON:0002780!7.80e-14!39;UBERON:0001890!7.80e-14!39;UBERON:0006240!7.80e-14!39;UBERON:0003080!1.69e-13!40;UBERON:0002616!8.56e-12!46;UBERON:0000955!1.50e-11!47;UBERON:0006238!1.50e-11!47;UBERON:0003056!4.27e-11!49;UBERON:0001049!1.77e-10!52;UBERON:0005068!1.77e-10!52;UBERON:0006241!1.77e-10!52;UBERON:0007135!1.77e-10!52;UBERON:0000073!4.19e-10!54;UBERON:0002368!3.96e-09!60;UBERON:0002346!1.41e-08!64;UBERON:0003075!1.41e-08!64;UBERON:0007284!1.41e-08!64;UBERON:0002530!1.88e-08!65;UBERON:0000949!1.17e-07!72;UBERON:0010371!1.48e-07!73;UBERON:0001017!1.48e-07!73;UBERON:0001016!2.31e-07!75 | |||
}} | }} |
Revision as of 21:00, 11 October 2012
Phase1 CAGE Peaks
Short description | |
---|---|
Mm9::chr10:110991047..110991081,+ | p@chr10:110991047..110991081 + |
Mm9::chr16:65521021..65521032,+ | p2@Pou1f1 |
Mm9::chr2:157397171..157397183,- | p14@Blcap |
Mm9::chr2:163862718..163862732,+ | p4@Pabpc1l |
Mm9::chr2:26060097..26060110,- | p@chr2:26060097..26060110 - |
Mm9::chr2:26060131..26060142,- | p@chr2:26060131..26060142 - |
Mm9::chr2:26060145..26060156,- | p@chr2:26060145..26060156 - |
Mm9::chr2:26060176..26060181,- | p@chr2:26060176..26060181 - |
Mm9::chr5:5314581..5314592,- | p@chr5:5314581..5314592 - |
Mm9::chr6:119217479..119217523,+ | p@chr6:119217479..119217523 + |
Mm9::chrX:139493649..139493658,+ | p@chrX:139493649..139493658 + |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process | 0.00375270495224433 |
GO:0032959 | inositol trisphosphate biosynthetic process | 0.00375270495224433 |
GO:0032958 | inositol phosphate biosynthetic process | 0.00375270495224433 |
GO:0032960 | regulation of inositol trisphosphate biosynthetic process | 0.00375270495224433 |
GO:0006021 | inositol biosynthetic process | 0.00375270495224433 |
GO:0043647 | inositol phosphate metabolic process | 0.00375270495224433 |
GO:0032957 | inositol trisphosphate metabolic process | 0.00375270495224433 |
GO:0060133 | somatotropin secreting cell development | 0.00375270495224433 |
GO:0060126 | somatotropin secreting cell differentiation | 0.00450312257623173 |
GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway | 0.00450312257623173 |
GO:0045913 | positive regulation of carbohydrate metabolic process | 0.0050033324553003 |
GO:0043255 | regulation of carbohydrate biosynthetic process | 0.0050033324553003 |
GO:0006109 | regulation of carbohydrate metabolic process | 0.00643250353835337 |
GO:0021984 | adenohypophysis development | 0.00643250353835337 |
GO:0008340 | determination of adult life span | 0.00700408972726694 |
GO:0048009 | insulin-like growth factor receptor signaling pathway | 0.00794538066611113 |
GO:0006020 | inositol metabolic process | 0.00794538066611113 |
GO:0010259 | multicellular organismal aging | 0.00833751668703983 |
GO:0021983 | pituitary gland development | 0.0142145434083468 |
GO:0021536 | diencephalon development | 0.0150009504920605 |
GO:0040018 | positive regulation of multicellular organism growth | 0.0150009504920605 |
GO:0001708 | cell fate specification | 0.0150009504920605 |
GO:0019319 | hexose biosynthetic process | 0.0150009504920605 |
GO:0046165 | alcohol biosynthetic process | 0.0150009504920605 |
GO:0046364 | monosaccharide biosynthetic process | 0.0150009504920605 |
GO:0045927 | positive regulation of growth | 0.0150009504920605 |
GO:0007568 | aging | 0.0155556883470946 |
GO:0030183 | B cell differentiation | 0.0187465618727708 |
GO:0035270 | endocrine system development | 0.0248141852991228 |
GO:0040014 | regulation of multicellular organism growth | 0.0259831151355832 |
GO:0035264 | multicellular organism growth | 0.0294896781300526 |
GO:0048732 | gland development | 0.0346440524221495 |
GO:0016051 | carbohydrate biosynthetic process | 0.0358591910391614 |
GO:0042113 | B cell activation | 0.0374417210532664 |
GO:0030098 | lymphocyte differentiation | 0.0393597288025601 |
GO:0003682 | chromatin binding | 0.0393961055216672 |
GO:0030900 | forebrain development | 0.0393961055216672 |
GO:0045165 | cell fate commitment | 0.0393961055216672 |
GO:0002521 | leukocyte differentiation | 0.0486140962192843 |
GO:0019318 | hexose metabolic process | 0.0486140962192843 |
GO:0005996 | monosaccharide metabolic process | 0.0488823455569572 |
GO:0031326 | regulation of cellular biosynthetic process | 0.0494922157546636 |
Relative expression of the co-expression cluster over median <br>Analyst:
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br><br>
Ontology term | p-value | n |
---|---|---|
pituitary gland | 3.71e-65 | 8 |
gland of diencephalon | 3.71e-65 | 8 |
neuroendocrine gland | 3.71e-65 | 8 |
diencephalon | 2.77e-52 | 10 |
future diencephalon | 2.77e-52 | 10 |
regional part of forebrain | 7.80e-14 | 39 |
forebrain | 7.80e-14 | 39 |
future forebrain | 7.80e-14 | 39 |
anterior neural tube | 1.69e-13 | 40 |
regional part of brain | 8.56e-12 | 46 |
brain | 1.50e-11 | 47 |
future brain | 1.50e-11 | 47 |
pre-chordal neural plate | 4.27e-11 | 49 |
neural tube | 1.77e-10 | 52 |
neural rod | 1.77e-10 | 52 |
future spinal cord | 1.77e-10 | 52 |
neural keel | 1.77e-10 | 52 |
regional part of nervous system | 4.19e-10 | 54 |
endocrine gland | 3.96e-09 | 60 |
neurectoderm | 1.41e-08 | 64 |
neural plate | 1.41e-08 | 64 |
presumptive neural plate | 1.41e-08 | 64 |
gland | 1.88e-08 | 65 |
endocrine system | 1.17e-07 | 72 |
ecto-epithelium | 1.48e-07 | 73 |
central nervous system | 1.48e-07 | 73 |
nervous system | 2.31e-07 | 75 |
TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
{{{tfbs_overrepresentation_jaspar}}} |